PACAP38 and PACAP6-38 Exert Cytotoxic Activity Against Human Retinoblastoma Y79 Cells

Journal of Molecular Neuroscience

Volumn 54, Issue 3, 2014, Pages 463-468

  Wojcieszak, Jakub ^a   Zawilska, Jolanta B ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Cytotoxicity; PAC1receptor; PACAP; Retinoblastoma; Y79 cells

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR 1; INSECT PROTEIN; MAXADILAN PROTEIN, INSECT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE INHIBITOR;

AGONISTS; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; HUMAN; METABOLISM; NERVE CELL; RETINOBLASTOMA; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; INSECT PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; PROTEIN KINASE INHIBITORS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RETINOBLASTOMA;

EID: 84893180401     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-014-0248-0     Document Type: Article

References (23)

1. Baun M, Pedersen MH, Olesen J, Jansen-Olesen I (2012) Dural mast cell degranulation is a putative mechanism for headache induced by PACAP-38. Cephalalgia 32:337–345
2. Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A (2008) Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Peptides 29:919–932
3. Bourgault S, Vaudry D, Ségalas-Milazzo I, Guilhaudis L, Couvineau A, Laburthe M, Vaudry H, Fournier A (2009) Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor. J Med Chem 52:3308–3316
4. Cohen JR, Resnick DZ, Niewiadomski P, Dong H, Liau LM, Waschek JA (2010) Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. BMC Cancer 10:676
5. Dautzenberg FM, Mevenkamp G, Wille S, Hauger RL (1999) N-terminal splice variants of the type I PACAP receptor: isolation, characterization and ligand binding/selectivity determinants. J Neuroendocrinol 11:941–949
6. Doan ND, Bourgault S, Dejda A, Létourneau M, Detheux M, Vaudry D, Vaudry H, Chatenet D, Fournier A (2011) Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects. Biochem Pharmacol 81:552–561
7. Doan ND, Chatenet D, Létourneau M, Vaudry H, Vaudry D, Fournier A (2012a) Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide. Biochim Biophys Acta 1823:940–949
8. Doan ND, Létourneau M, Vaudry D, Doucet N, Folch B, Vaudry H, Fournier A, Chatenet D (2012b) Design and characterization of novel cell-penetrating peptides from pituitary adenylate cyclase-activating polypeptide. J Control Release 163:256–265
9. Felley CP, Qian JM, Mantey S, Pradhan T, Jensen RT (1992) Chief cells possess a receptor with high affinity for PACAP and VIP that stimulates pepsinogen release. Am J Physiol 263:G901–G907
10. Gutiérrez-Cañas I, Rodríguez-Henche N, Bolaños O, Carmena MJ, Prieto JC, Juarranz MG (2003) VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br J Pharmacol 139:1050–1058
11. Ichinose M, Asai M, Imai K, Sawada M (1995) Enhancement of phagocytosis in mouse macrophages by pituitary adenylate cyclase activating polypeptide (PACAP) and related peptides. Immunopharmacol 30:217–224
12. Juhasz T, Matta C, Katona E, Somogyi C, Takacs R, Kolozsvari B, Csernoch L, Panyi G, Toth G, Reglodi D, Tamas A, Zakany R (2013) Pituitary adenylate cyclase activating peptide (PACAP)-signalling promotes chondriogenesis: implication of calcineurin as a downstream target. J Mol Neurosci 51(Suppl 1):S229. doi:10.1007/s12031-013-0105-6
13. Lelièvre V, Meunier AC, Caigneaux E, Falcon J, Muller JM (1998) Differential expression and function of PACAP and VIP receptors in four human colonic adenocarcinoma cell lines. Cell Signal 10:13–26
14. Lin Y, Hall RA, Kuhar MJ (2011) CART peptide stimulation of G protein-mediated signaling in differentiated PC12 cells: identification of PACAP 6-38 as a CART receptor antagonist. Neuropeptides 45:351–358
15. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567–574
16. Nemetz N, Abad C, Lawson G, Nobuta H, Chhith S, Duong L, Tse G, Braun J, Waschek JA (2008) Induction of colitis and rapid development of colorectal tumors in mice deficient in the neuropeptide PACAP. Int J Cancer 122:1803–1809
17. Olianas MC, Ennas MG, Lampis G, Onali P (1996) Presence of pituitary adenylate cyclase-activating polypeptide receptors in Y-79 human retinoblastoma cells. J Neurochem 67:1293–1300
18. Reglodi D, Borzsei R, Bagoly T, Boronkai A, Racz B, Tamas A, Kiss P, Horvath G, Brubel R, Nemeth J, Toth G, Helyes Z (2008) Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cells. J Mol Neurosci 36:270–278
19. Sokołowska P, Nowak JZ (2008) Effects of PACAP and VIP on cAMP-generating system and proliferation of C6 glioma cells. J Mol Neurosci 36:286–291
20. Vaudry D, Falluel-Morel A, Bourgault S, Basille M, Burel D, Wurtz O, Fournier A, Chow BK, Hashimoto H, Galas L, Vaudry H (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357
21. Wang X, Wei H, Zhao T, Zhu X, Yang X, Chen D, Zhou H (2013) Evidence for pituitary adenylate cyclase-activating peptide as a direct immunoregulator in teleost head kidney. Fish Shellfish Immunol 34:265–272
22. Yu R, Zhong J, Li M, Guo X, Zhang H, Chen J (2013) PACAP induces the dimerization of PAC1 on the nucleus associated with the cAMP increase in the nucleus. Neurosci Lett 549:92–96
23. Zhu L, Tamvakopoulos C, Xie D, Dragovic J, Shen X, Fenyk-Melody JE, Schmidt K, Bagchi A, Griffin PR, Thornberry NA, Sinha Roy R (2003) The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). J Biol Chem 278:22418–22423